2,8 This review aims to explore the role of GLP-1 RAs as add-on therapy to basal insulin, as an alternative to prandial or rapid-acting insulin
Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Zhang J, Sepesi B, Vaporciyan AA, Swisher SG , Heymach JV, Zhang J, Gomez DR, Antonoff MB
Work with an interdisciplinary team to tackle thorny problems
Carbohydrates and colorectal cancer risk among Chinese in North America
The package includes two design options of the one-page consent form to support any GLP-1 weight loss treatments that you offer
Individuals considering GLP-1 agonists for binge eating disorder should engage in thorough, collaborative discussions with healthcare providers who understand both the medications and eating disorders